Eris Lifesciences Ltd

Chart & Performance

D1W1MN

P/E

60.98

P/S

7.45

EPS

25.83

Div Yield, %

—

Shrs. gr., 5y

-0.14%

Rev. gr., 5y

22.16%

Revenues

28.79b

+44.59%

Net income

3.52b

-10.24%

CFO

10.65b

+119.14%

Dividend

Aug 11, 20227.35 INR/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.

URL

https://eris.co.in/

IPO date

Jun 29, 2017

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title INR in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title INR in thousands, except ratios and share amounts	2025‑03	2024‑03	2023‑03	2022‑03	2021‑03	2020‑03	2019‑03	2018‑03	2017‑03	2016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT